DBDaniela Buccella

Daniela Buccella

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Daniela Buccella has a total of 162 co-authors. Here are the top co-authors by number of shared publications:

  • Gerard Parkin

    Department of Chemistry, Columbia University, New York, New York 10027

    10 shared publications
  • Jonathan G. Melnick

    Department of Chemistry, Columbia University, New York, New York, USA

    6 shared publications
  • Gerard Parkin

    Columbia University

    5 shared publications
  • Keliang Pang

    Molecular Logic Gate Laboratory, Department of Chemistry and School of Molecular Science -BK 21, Korea Advanced Institute of Science and Technology (KAIST), 373-1 Guseong-dong, Yuseong-gu, Daejeon, 305-701, Republic of Korea, and Department of Chemistry, Columbia University, 3000 Broadway, New York, New York 10027

    4 shared publications
  • Kevin Yurkerwich

    Department of Chemistry, Columbia University, New York, New York, USA

    4 shared publications
  • Matthew Carnes

    Department of Chemistry and The Center for Electron Transport in Molecular Nanostructures, Columbia University, New York, NY 10027 (USA), Fax: (+1) 212-932-1289 http://nuckolls.chem.columbia.edu

    4 shared publications

Latest Publications

  • Open Access

    Enhanced Ratiometric Indicators for (Sub)cellular Detection of Magnesium(II) Ions by Flow Cytometry

    by Michael Brady, Mu-Chun Liu, Veronika Shchepetkina, Daniela Buccella

    Magnesium(II) plays essential roles in cellular physiology, yet the inner workings of its cellular distribution and transport remain challenging to study due to the scarcity of tools for Mg2+-selective detection with high spatiotemporal resolution and compatible with high-throughput analysis. We report herein MagZet2, a next-generation ratiometric fluorescent sensor featuring a quinoline dicarboxylate motif with an expanded dynamic range for Mg2+ detection by fluorescence microscopy and flow cytometry. MagZet2 displays excellent Mg2+/Ca2+ selectivity and an apparent dissociation constant, K′d = 0.4 mM, well matched to physiological free Mg2+ concentrations in mammalian cells. By conjugation to HaloTag, we further engineer MagZet2 into chemigenetic indicators that retain desirable photophysical properties of the small molecule counterpart while enabling genetically encoded control of subcellular localization. Using a hybrid sensor, MagZet2(L2)Halo, we demonstrate the first organelle-resolved Mg2+ detection by flow cytometry, a technique that does not inherently offer spatial resolution. Finally, we apply MagZet2(L2)Halo to monitor Mg2+ uptake kinetics in live Caco-2 cells, revealing transport dynamics that parallel those measured using destructive 25Mg transport assays while offering improved temporal resolution and compatibility with live-cell analysis. Together, these results establish MagZet2 and its chemigenetic derivatives as powerful tools for organelle-resolved, high-throughput interrogation of free Mg2+ in living cells.

  • Open Access

    Imaging intracellular zinc by stimulated Raman scattering microscopy with a small molecule vibrational probe

    by Elsy El Khoury, Symara de Melo Silva, Naixin Qian, Vinh Gia Vuong, Wei Min, Daniela Buccella

    A spiropyran molecular probe with a strategically positioned nitrile undergoes reversible changes in its vibrational spectrum that enable ratiometric imaging of Zn 2+ , and paramagnetic ions, in live cells by Stimulated Raman Scattering microscopy.


  • Open Access

    microRNAs Regulate Cellular Magnesium by Tuning Expression of the Plasma Membrane Protein CNNM4

    by Tomas S. Lazarou, Helia Dehghan Harati, Lara K. Mahal, Daniela Buccella

    Cyclin M4 (CNNM4) is a plasma membrane Mg2+ transporter that is important for the regulation of cellular and organismal Mg2+ homeostasis. CNNM4 is overexpressed in liver diseases, including non-alcoholic steatohepatitis and acetaminophen-induced liver injury, leading to aberrant levels of Mg2+. The regulatory mechanisms underlying the overexpression of this protein, however, remain unknown. Here, we demonstrate regulation of CNNM4 and cellular magnesium levels by microRNA. Using a high-throughput assay, we established the complete miRNA binding profile of the 3'UTR of the gene. Both upregulation and downregulation of CNNM4 were observed, though upregulatory activity appears more prominent. We demonstrate that in both cases, the effects arise from direct binding of the miRNAs to the CNNM4-3'UTR, and we provide direct evidence that they result in changes of cellular concentration of the metal in hepatocytes. The results reveal a potential role of microRNAs in the alteration of magnesium homeostasis in the liver through CNNM4 and, based on the miRNA proxy hypothesis, predict a broader role of CNNM4 and aberrant magnesium levels in breast cancer and other pathologies.


  • Supramolecular inorganic chemistry: from form to function

    by Daniela Buccella, Raúl Hernández Sánchez, Janet R. Morrow, Valérie C. Pierre, Justin J. Wilson


  • Open Access

    Modulatory effects of CNNM4 on protein-l-isoaspartyl-O-methyltransferase repair function during alcohol-induced hepatic damage

    by Irene González-Recio, Naroa Goikoetxea-Usandizaga, Claudia M. Rejano-Gordillo, Carolina Conter, Rubén Rodríguez Agudo, Marina Serrano-Maciá, Leidy Estefanía Zapata-Pavas, Patricia Peña-Sanfélix, Mikel Azkargorta, Félix Elortza, et al.

    Background and Aims: Alcohol-associated liver disease (ALD) is a leading cause of liver-related mortality worldwide, with limited treatment options beyond abstinence and liver transplantation. Chronic alcohol consumption has been linked to magnesium (Mg2+) deficiency, which can influence liver disease progression. The mechanisms underlying Mg2+ homeostasis dysregulation in ALD remain elusive. This study aimed to investigate the role of the Mg2+ transporter Cyclin M4 (CNNM4) in ALD by analyzing its expression patterns in patients with ALD and preclinical animal models. Approach and Results: In this study, CNNM4 is upregulated in the liver of both patients with ALD and animal models. CNNM4 overexpression triggers Mg2+ homeostasis dysregulation, linked to ALD progression. We propose a novel therapeutic approach for ALD treatment using N-acetylgalactosamine silencing RNA technology to specifically modulate Cnnm4 expression in the liver, improving mitochondrial function and alleviating endoplasmic reticulum stress. Notably, silencing Cnnm4 restores protein isoaspartyl methyltransferase (PCMT1) activity, essential for repairing ethanol-induced protein damage. Enhancing mitochondrial activity through Cnnm4-dependent mechanisms increases S-adenosylmethionine levels, crucial for PCMT1 function, highlighting the interconnected roles of mitochondrial health and protein homeostasis in ALD treatment. Conclusions: These findings shed light on the dysregulation of Mg2+ homeostasis in ALD, providing a promising therapeutic approach targeting CNNM4. N-acetylgalactosamine siCnnm4 therapy boosts the repair processes of ethanol-damaged proteins through the upregulation of PCMT1 activity.


  • Open Access

    Ratiometric Fluorescent Sensors Illuminate Cellular Magnesium Imbalance in a Model of Acetaminophen-Induced Liver Injury

    by Michael Brady, Veronika I. Shchepetkina, Irene González-Recio, María L. Martínez-Chantar, Daniela Buccella

    Magnesium­(II) plays catalytic, structural, regulatory, and signaling roles in living organisms. Abnormal levels of this metal have been associated with numerous pathologies, including cardiovascular disease, diabetes, metabolic syndrome, immunodeficiency, cancer, and, most recently, liver pathologies affecting humans. The role of Mg2+ in the pathophysiology of liver disease, however, has been occluded by concomitant changes in concentration of interfering divalent cations, such as Ca2+, which complicates the interpretation of experiments conducted with existing molecular Mg2+ indicators. Herein, we introduce a new quinoline-based fluorescent sensor, MagZet1, that displays a shift in its excitation and emission wavelengths, affording ratiometric detection of cellular Mg2+ by both fluorescence microscopy and flow cytometry. The new sensor binds the target metal with a submillimolar dissociation constantwell suited for detection of changes in free Mg2+ in cellsand displays a 10-fold selectivity against Ca2+. Furthermore, the fluorescence ratio is insensitive to changes in pH in the physiological range, providing an overall superior performance over existing indicators. We provide insights into the metal selectivity profile of the new sensor based on computational modeling, and we apply it to shed light on a decrease in cytosolic free Mg2+ and altered expression of metal transporters in cellular models of drug-induced liver injury caused by acetaminophen overdose.


  • Lanthanide-based luminescent probes for biological magnesium: accessing polyphosphate-bound Mg2+

    by Brismar Pinto-Pacheco, Qitian Lin, Claudia W. Yan, Symara de Melo Silva, Daniela Buccella

    New Eu(iii)-based indicators enable luminescence-based detection of polyphosphate-bound Mg2+ species, a highly dynamic pool of biomolecule-bound magnesium in cells.


  • Open Access

    Restoring cellular magnesium balance through Cyclin M4 protects against acetaminophen-induced liver damage

    by Irene González-Recio, Jorge Simón, Naroa Goikoetxea-Usandizaga, Marina Serrano-Maciá, Maria Mercado-Gómez, Rubén Rodríguez-Agudo, Sofía Lachiondo-Ortega, Clàudia Gil-Pitarch, Carmen Fernández-Rodríguez, Donatello Castellana, et al.

    Acetaminophen overdose is one of the leading causes of acute liver failure and liver transplantation in the Western world. Magnesium is essential in several cellular processess. The Cyclin M family is involved in magnesium transport across cell membranes. Herein, we identify that among all magnesium transporters, only Cyclin M4 expression is upregulated in the liver of patients with acetaminophen overdose, with disturbances in magnesium serum levels. In the liver, acetaminophen interferes with the mitochondrial magnesium reservoir via Cyclin M4, affecting ATP production and reactive oxygen species generation, further boosting endoplasmic reticulum stress. Importantly, Cyclin M4 mutant T495I, which impairs magnesium flux, shows no effect. Finally, an accumulation of Cyclin M4 in endoplasmic reticulum is shown under hepatoxicity. Based on our studies in mice, silencing hepatic Cyclin M4 within the window of 6 to 24 h following acetaminophen overdose ingestion may represent a therapeutic target for acetaminophen overdose induced liver injury.


  • Intracellular Localization Studies of the Luminescent Analogue of an Anticancer Ruthenium Iminophosphorane with High Efficacy in a Triple-Negative Breast Cancer Mouse Model

    by Kirill Miachin, Virginia Del Solar, Elsy El Khoury, Nazia Nayeem, Anton Khrystenko, Patricia Appelt, Michelle C. Neary, Daniela Buccella, Maria Contel

    The potential of ruthenium(II) compounds as an alternative to platinum-based clinical anticancer agents has been unveiled after extensive research for over 2 decades. As opposed to cisplatin, ruthenium(II) compounds have distinct mechanisms of action that do not rely solely on interactions with DNA. In a previous report from our group, we described the synthesis, characterization, and biological evaluation of a cationic, water-soluble, organometallic ruthenium(II) iminophosphorane (IM) complex of p-cymene, ([(η6-p-cymene)Ru{(Ph3P═N-CO-2N-C5H4)-κ-N,O}Cl]Cl (1 or Ru-IM), that was found to be highly cytotoxic against a panel of cell lines resistant to cisplatin, including triple-negative breast cancer (TNBC) MDA-MB-231, through canonical or caspase-dependent apoptosis. Studies on a MDA-MB-231 xenograft mice model (after 28 days of treatment) afforded an excellent tumor reduction of 56%, with almost negligible systemic toxicity, and a favored ruthenium tumor accumulation compared to other organs. 1 is known to only interact weakly with DNA, but its intracellular distribution and ultimate targets remain unknown. To gain insight on potential mechanisms for this highly efficacious ruthenium compound, we have developed two luminescent analogues containing the BOPIPY fluorophore (or a modification) in the IM scaffold with the general structure of [(η6-p-cymene)Ru{(BODIPY-Ph2P═N-CO-2-NC5H4)-κ-N,O}Cl]Cl {BODIPY-Ph2P = 8-[(4-diphenylphosphino)phenyl]-4,4-dimethyl-1,3,5,7-tetramethyl-2,6-diethyl-4-bora-3a,4a-diaza-s-indacene (3a) and 4,4-difluoro-8-[4-[[2-[4-(diphenylphosphino)benzamido]ethyl]carbamoyl]phenyl]-1,3,5,7-tetramethyl,2,6-diethyl-4-bora-3a,4a-diaza-s-indacene (3b)}. We report on the synthesis, characterization, lipophilicity, stability, luminescence properties, and cell viability studies in the TNBC cell line MDA-MB-231, nonmalignant breast cells (MCF10a), and lung fibroblasts (IMR-90) of the new compounds. The ruthenium derivative 3b was studied by fluorescence confocal microscopy. These studies point to a preferential accumulation of the compound in the endoplasmic reticulum, mitochondria, and lysosomes. Inductively coupled plasma optical emission spectrometry (ICP-OES) analysis also confirms a greater ruthenium accumulation in the cytoplasmic fraction, including endoplasmic reticulum and lysosomes, and a smaller percentage of accumulation in mitochondria and the nucleus. ICP-OES analysis of the parent compound 1 indicates that it accumulates preferentially in the mitochondria and cytoplasm. Subsequent experiments in 1-treated MDA-MB-231 cells demonstrate significant reactive oxygen species generation.